Free Writing Prospectus
Filed Pursuant to Rule 433
Dated July 25, 2017
Registration Statement Nos. 333-205778 and 333-205778-07
FULL PXING-- $1.2BN+ Offered Toyota Auto Receivables 2017-C Owner Trust
Joint Leads: Citi (str.), BNPP, Mizuho
Comanagers: Commerzbank, Fifth Third Securities, US Bancorp
Anticipated Capital Structure:
| | Note | Offered | | | | | | | | |
| Class | Amt($mm) | Amt($mm)** | M/S*** | WAL## | L.Fin | Bench | Sprd | YLD | CPN | $PX |
| A-1 | 443.000 | -- | P-1/A-1+ | 0.29 | -Not Offered- |
| A-2a | 460.000 | 437.000 | Aaa/AAA | 1.16 | 07/15/20 | EDSF+ | 8 | 1.586 | 1.58 | 99.99905 |
| A-2b | 240.000 | 228.000 | Aaa/AAA | 1.16 | 07/15/20 | 1mL+ | 8 | | 1mL+8bps | 100.00000 |
| A-3 | 420.000 | 399.000 | Aaa/AAA | 2.41 | 11/15/21 | iSwps+ | 11 | 1.790 | 1.78 | 99.99203 |
| A-4 | 143.250 | 136.087 | Aaa/AAA | 3.46 | 12/15/22 | iSwps+ | 19 | 1.993 | 1.98 | 99.98397 |
| B | 43.750 | -- | A1/AA+ | 3.70 | -Not Offered- |
| ** | Offered Notes (95% of A-2 through A-4 notes) |
| *** | Expected Ratings |
| ## | WAL to 5% Call, 1.3% ABS |
| Ticker: | TAOT 2017-C |
| Registration: | SEC Registered |
| Expected Ratings: | M/S |
| | |
| Settle: | 8/02/2017 |
| First Payment: | 9/15/2017 |
| Pay Date: | Monthly on the 15th (or next business day) |
| Min Denoms: | $1k x $1k |
| ERISA Eligible: | Yes |
| Bill and Deliver: | Citi |
| Delivery: | DTC, Euroclear, Clearstream |
------------------------------------------------------------
The issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Website at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling toll-free 1-800-831-9146.
